Wittington Ventures

Wittington Ventures is a Toronto-based venture capital firm that focuses on investing in companies at all stages of the start-up lifecycle. Established in 2019, it specializes in technology-oriented sectors, including e-commerce, retail, healthcare, and food. The firm prioritizes investments across North America and leverages its strong connections with well-known Canadian brands to support entrepreneurs and their ventures effectively. Through its strategic investments, Wittington Ventures aims to foster innovation and growth in the businesses it partners with.

Megh Gupta

Partner

Carley-Rose Horowitz

Associate

Qasim Mohammad

Partner

Jim Orlando

Managing Partner

Nick Taylor

Senior Associate

Darian Zigante

Senior Associate

22 past transactions

Grey Matter Neurosciences

Seed Round in 2025
Grey Matter Neurosciences is a neurotechnology company specializing in the development of innovative medical devices and drug-device combinations to address age-related brain disorders, with a primary focus on dementia. Their flagship technology is a portable ultrasound helmet, designed to non-invasively enhance brain function in seniors with Alzheimer's disease.

Noetik

Series A in 2024
Noetik is an AI-native biotechnology company focused on the discovery and development of cancer immunotherapies. Utilizing advanced machine learning techniques, Noetik's platform identifies new therapeutic targets and designs innovative treatments. By harnessing self-supervised learning and integrating diverse human multimodal data, the company aims to enhance the precision and effectiveness of immunotherapies. This approach enables the development of more personalized cancer treatments, contributing to the advancement of targeted therapies in oncology.

Truvian Sciences

Venture Round in 2024
Truvian Sciences Inc. is a diagnostic company based in San Diego, California, focused on revolutionizing the blood testing industry. Incorporated in 2015, the company has developed an automated benchtop system that delivers lab-accurate results for a variety of health tests. Its comprehensive wellness panel includes commonly ordered routine blood tests such as complete blood count, metabolic panel, and lipid panel, all from a single sample. Additionally, Truvian's software system enables healthcare practitioners to efficiently deliver test results to patients through a user-friendly platform.

Abridge

Series C in 2024
Abridge is a healthcare technology company that uses generative AI to automate transcription and summarization of medical conversations. The platform turns patient-clinician discussions into structured clinical notes in real time and integrates with electronic health record systems. By reducing manual note-taking, it helps clinicians capture key details while producing clear summaries for patients, and ensures documentation is added to patient records. Abridge emphasizes data security and patient privacy, complies with healthcare regulations, and provides a customizable interface aligned with clinical workflows and patient needs.

Unlearn.AI

Series C in 2024
Unlearn.AI, Inc. is a biotechnology company based in San Francisco, California, that specializes in developing innovative software tools for clinical research. Established in 2017, Unlearn.AI focuses on enhancing clinical trials through its unique digital twin technology, known as TwinRCT. This approach utilizes machine learning to create prognostic digital twins for individual patients, allowing for more accurate estimations of treatment effects while reducing the number of participants needed. The company also offers services for Clinical Trial Design, which helps determine inclusion criteria, endpoints, and study sizes, as well as Synthetic Control Arms that can minimize or eliminate the need for concurrent control groups. Additionally, Unlearn.AI provides Subgroup Analysis to identify and analyze specific patient subgroups within trial results. By integrating expertise from pharmaceuticals, medical technology, and machine learning, Unlearn.AI aims to transform clinical trials to improve outcomes for both patients and sponsors.

ODAIA

Series B in 2023
ODAIA is a technology company offering an AI-powered customer data platform for the life sciences industry. Its platform blends data analysis, process mining, and artificial intelligence to deliver goal-driven commercial insights and automate processes as a software-as-a-service. It supports personalized selling by helping pharmaceutical teams map customer journeys and optimize engagement to ensure therapeutics reach patients who need them.

Unlearn.AI

Venture Round in 2023
Unlearn.AI, Inc. is a biotechnology company based in San Francisco, California, that specializes in developing innovative software tools for clinical research. Established in 2017, Unlearn.AI focuses on enhancing clinical trials through its unique digital twin technology, known as TwinRCT. This approach utilizes machine learning to create prognostic digital twins for individual patients, allowing for more accurate estimations of treatment effects while reducing the number of participants needed. The company also offers services for Clinical Trial Design, which helps determine inclusion criteria, endpoints, and study sizes, as well as Synthetic Control Arms that can minimize or eliminate the need for concurrent control groups. Additionally, Unlearn.AI provides Subgroup Analysis to identify and analyze specific patient subgroups within trial results. By integrating expertise from pharmaceuticals, medical technology, and machine learning, Unlearn.AI aims to transform clinical trials to improve outcomes for both patients and sponsors.

Abridge

Series A in 2022
Abridge is a healthcare technology company that uses generative AI to automate transcription and summarization of medical conversations. The platform turns patient-clinician discussions into structured clinical notes in real time and integrates with electronic health record systems. By reducing manual note-taking, it helps clinicians capture key details while producing clear summaries for patients, and ensures documentation is added to patient records. Abridge emphasizes data security and patient privacy, complies with healthcare regulations, and provides a customizable interface aligned with clinical workflows and patient needs.

goConfirm

Seed Round in 2022
goConfirm brings trust to online interactions everywhere. With a secure, verified ConfirmID, based on authentic government-issued ID and backed by state-of-the-art digital protocols, people around the world will have a secure, portable, reliable way to share and exchange their identity in everything they do online.

FOXTROT

Series C in 2022
Foxtrot Ventures, Inc., established in 2013 and headquartered in Chicago, Illinois, is a food and beverage delivery company. It operates a mobile application and website, enabling users to shop for a wide range of products, including wine, spirits, groceries, ice cream, and essential household items. Foxtrot also owns and operates physical grocery stores in Chicago and Texas, further expanding its reach. The company delivers orders directly to customers within an hour of purchase.

League

Series C in 2021
League is a platform technology company focused on enhancing healthcare consumer experiences through its digital health platform. This platform is designed to deliver personalized health experiences, facilitating a digital transformation in the healthcare sector. By providing a robust infrastructure, League enables healthcare providers, partners, and employers to manage costs, increase utilization, and improve care for their populations. The company's approach aims to meet consumers in various settings, driving measurable outcomes in health engagement and overall wellness.

Arcaea

Series A in 2021
Arcaea is a biotechnology company dedicated to transforming the beauty and personal care industry by leveraging biology as a creative tool for self-expression. The company aims to develop innovative ingredients and product experiences through advanced technologies such as DNA sequencing, biological engineering, and fermentation. By focusing on the potential of biology, Arcaea seeks to create sustainable and eco-friendly ingredients, thereby offering the beauty industry new options that minimize environmental impact. Through its pioneering approach, Arcaea aspires to redefine the future of beauty by unlocking previously unattainable product capabilities.

Gatik

Series B in 2021
Gatik is a startup focused on developing autonomous technology for light and medium-duty trucks aimed at B2B short-haul logistics. Founded in 2017 and headquartered in Mountain View, California, the company specializes in artificial intelligence and automotive technology. Gatik's software is designed to facilitate SAE Level 4 autonomy for commercial vehicles, specifically Class 3 to Class 7 trucks and vans. This technology is tailored for middle-mile logistics, allowing customers to efficiently meet scheduled delivery requirements.

Motif

Series B in 2021
Motif FoodWorks, Inc. is a bio-organism engineering company based in Boston, Massachusetts, that specializes in developing innovative food ingredients. The company focuses on producing animal-free proteins, including meat alternatives and dairy-free proteins, catering to the growing demand for plant-based food solutions. By utilizing fermentation technology, Motif creates essential proteins and nutrients that enhance both nutrition and flavor in food products. The company collaborates with chefs, health experts, and food innovators to develop new ingredient solutions aimed at transforming the food industry and promoting sustainability. Established in 2018 and originally known as Motif Ingredients, Motif FoodWorks rebranded in 2019 to reflect its commitment to advancing the next generation of healthy and plant-based foods.

Truvian Sciences

Series C in 2021
Truvian Sciences Inc. is a diagnostic company based in San Diego, California, focused on revolutionizing the blood testing industry. Incorporated in 2015, the company has developed an automated benchtop system that delivers lab-accurate results for a variety of health tests. Its comprehensive wellness panel includes commonly ordered routine blood tests such as complete blood count, metabolic panel, and lipid panel, all from a single sample. Additionally, Truvian's software system enables healthcare practitioners to efficiently deliver test results to patients through a user-friendly platform.

FOXTROT

Series B in 2021
Foxtrot Ventures, Inc., established in 2013 and headquartered in Chicago, Illinois, is a food and beverage delivery company. It operates a mobile application and website, enabling users to shop for a wide range of products, including wine, spirits, groceries, ice cream, and essential household items. Foxtrot also owns and operates physical grocery stores in Chicago and Texas, further expanding its reach. The company delivers orders directly to customers within an hour of purchase.

Gatik

Series A in 2020
Gatik is a startup focused on developing autonomous technology for light and medium-duty trucks aimed at B2B short-haul logistics. Founded in 2017 and headquartered in Mountain View, California, the company specializes in artificial intelligence and automotive technology. Gatik's software is designed to facilitate SAE Level 4 autonomy for commercial vehicles, specifically Class 3 to Class 7 trucks and vans. This technology is tailored for middle-mile logistics, allowing customers to efficiently meet scheduled delivery requirements.

Nurx

Series C in 2020
Nurx Inc. is a digital healthcare company based in San Francisco, California, that offers a mobile health platform designed to provide easy access to a variety of everyday medications, including contraceptives, migraine treatments, and other health services. Founded in 2015, Nurx allows users to request prescriptions and receive home delivery of medications without the need for in-person doctor visits. The company combines telehealth services with at-home testing options, such as the Home HPV Screening test, empowering women to take charge of their health. Nurx operates in multiple states across the United States, providing transparent pricing and judgment-free care to enhance healthcare accessibility. By leveraging proprietary technology, Nurx aims to deliver convenient, affordable, and personalized healthcare solutions to its patients.

Contentful

Series E in 2020
Contentful GmbH, established in 2011, is a technology company headquartered in Berlin, Germany, with additional offices in San Francisco and Denver. It specializes in developing a cloud-based content management platform, Contentful, designed to streamline digital experiences for businesses. Contentful enables companies to create, manage, and distribute content across multiple channels, including web and mobile applications, at a faster pace and larger scale than traditional CMS solutions. It unifies content in a single hub, structures it for use in any digital channel, and integrates seamlessly with other tools through open APIs. Contentful serves a diverse range of clients, including 30% of the Fortune 500 and prominent brands like Chanel, Shopify, and BP.

FOXTROT

Series A in 2020
Foxtrot Ventures, Inc., established in 2013 and headquartered in Chicago, Illinois, is a food and beverage delivery company. It operates a mobile application and website, enabling users to shop for a wide range of products, including wine, spirits, groceries, ice cream, and essential household items. Foxtrot also owns and operates physical grocery stores in Chicago and Texas, further expanding its reach. The company delivers orders directly to customers within an hour of purchase.

League

Corporate Round in 2019
League is a platform technology company focused on enhancing healthcare consumer experiences through its digital health platform. This platform is designed to deliver personalized health experiences, facilitating a digital transformation in the healthcare sector. By providing a robust infrastructure, League enables healthcare providers, partners, and employers to manage costs, increase utilization, and improve care for their populations. The company's approach aims to meet consumers in various settings, driving measurable outcomes in health engagement and overall wellness.

League

Series B in 2018
League is a platform technology company focused on enhancing healthcare consumer experiences through its digital health platform. This platform is designed to deliver personalized health experiences, facilitating a digital transformation in the healthcare sector. By providing a robust infrastructure, League enables healthcare providers, partners, and employers to manage costs, increase utilization, and improve care for their populations. The company's approach aims to meet consumers in various settings, driving measurable outcomes in health engagement and overall wellness.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.